Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06563726 · ClinicalTrials.gov registry record · NA

Sodium Awareness in Lactation Trial

A NA study of Preterm Birth and Breastfeeding, sponsored by The Hospital for Sick Children.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06563726: Recruiting NA study of Preterm Birth and Breastfeeding, sponsored by The Hospital for Sick Children.

NCT06563726 is a NA study of Preterm Birth and Breastfeeding that is actively recruiting participants, run by The Hospital for Sick Children. The registered enrollment target is 40 participants, below the 4,408-participant average among 39 other Preterm Birth trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06563726, a NA study of Preterm Birth and Breastfeeding, is actively recruiting participants, sponsored by The Hospital for Sick Children.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

SALT is a multi-centre, non-blinded, non-randomized prospective interventional pilot study teaching lactating parents of hospitalized preterm infants how to test their breastmilk sodium (Na) using point-of-care (POC) meters. A drop in Na is a sign of secretory activation in the breast that is associated with adequate short and long-term breast milk volumes in this vulnerable population. Primary Objective: Establish feasibility, acceptance, and time cost of parent-led parent milk Na testing in the first 14 days postpartum Secondary Objective: Further investigate relationships between pumping behaviours, lactation risk factors, daily milk Na and lactation outcomes Exploratory Objective: Explore how POC Na data may be used to modify pumping behaviour and milk volumes

Primary Outcome

We will collect time cost of milk testing, including teaching parents how to test milk and daily time testing milk. This outcome will include time (in hours) spent in the first 14 days for parent and staff, with a health economist determining costs for that time

Interventions

  • DIAGNOSTIC_TEST point-of-care milk sodium testing

Study Locations (2)

Washington

  • Seattle Children's Hospital - Seattle
  • University of Washington Medical Center - Montlake - Seattle

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-03-10
Est. Completion 2026-03
Phase NA
The Hospital for Sick Children

23 total trials

What NCT06563726 shows while recruiting

NCT06563726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 4,408-participant average among 39 other Preterm Birth trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which point-of-care milk sodium testing is the first listed.

NCT06563726 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06563726 about?

NCT06563726 is a clinical study titled "Sodium Awareness in Lactation Trial". SALT is a multi-centre, non-blinded, non-randomized prospective interventional pilot study teaching lactating parents of hospitalized preterm infants how to test their breastmilk sodium (Na) using point-of-care (POC) meters. A drop in Na is a sign of secretory activation in the breast that is associ...

What is the current status of trial NCT06563726?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-10. Estimated completion is 2026-03.

What conditions does trial NCT06563726 study?

This clinical trial studies the following conditions: Preterm Birth, Breastfeeding, Breast Pumping, Lactation; Insufficient, Partial.

What interventions are being tested in trial NCT06563726?

The interventions under investigation include: point-of-care milk sodium testing (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06563726?

This trial is sponsored by The Hospital for Sick Children, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06563726 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Preterm Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06563726's enrollment target sits among peer trials

40 34th of 39 higher than 4 of 39 other Preterm Birth trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06563726, the US trial registry maintained by the National Library of Medicine. NCT06563726 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.